Invesco Ltd. Pro Phase Labs, Inc. Transaction History
Invesco Ltd.
- $453 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding PRPH
# of Institutions
32Shares Held
1.66MCall Options Held
2.4KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA619KShares$2.59 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny235KShares$981,4890.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL154KShares$642,2520.0% of portfolio
-
Geode Capital Management, LLC Boston, MA138KShares$578,5570.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL85.7KShares$358,2260.31% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $67M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...